|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.92 USD | +1.48% |
|
+0.74% | -1.77% |
| 13/05 | Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM | |
| 06/05 | Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026 |
| Market Cap | 279.81Cr 244.58Cr 226.19Cr 207.56Cr 392.83Cr 27TCr 399.65Cr 2.7TCr 1.06TCr 13TCr 1.05TCr 1.03TCr 45TCr | P/E 2026 * |
108x | P/E 2027 * | 32.2x |
|---|---|---|---|---|---|
| Enterprise Value | 279.81Cr 244.58Cr 226.19Cr 207.56Cr 392.83Cr 27TCr 399.65Cr 2.7TCr 1.06TCr 13TCr 1.05TCr 1.03TCr 45TCr | EV / Sales 2026 * |
3.23x | EV / Sales 2027 * | 2.74x |
| Free-Float |
95.54% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supernus Pharmaceuticals, Inc.
| 1 day | +1.49% | ||
| 1 week | +0.74% | ||
| Current month | +4.97% | ||
| 1 month | +12.02% | ||
| 3 months | -5.00% | ||
| 6 months | -2.01% | ||
| Current year | -1.77% |
| 1 week | 46.09 | 49.06 | |
| 1 month | 43.54 | 51.37 | |
| Current year | 42.45 | 59.68 | |
| 1 year | 32.2 | 59.68 | |
| 3 years | 21.99 | 59.68 | |
| 5 years | 21.99 | 59.68 | |
| 10 years | 13.12 | 61.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Khattar
CEO | Chief Executive Officer | 64 | 22/12/2005 |
Timothy Dec
DFI | Director of Finance/CFO | 67 | 23/08/2021 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 65 | 23/03/2015 |
Charles Newhall
CHM | Chairman | 81 | 10/08/2016 |
Frederick Hudson
BRD | Director/Board Member | 80 | 16/11/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/03/26 | Fiscal year | Chief Technology Officer | 3,21,750 | 0.5738% | ||
| 13/03/26 | Others | Founder | 60,000 | 0.1070% | ||
| 12/03/26 | Sell | Director | 5,369 | 0.0096% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.48% | +0.74% | +45.34% | +65.89% | 279.81Cr | ||
| +2.91% | +5.95% | +60.56% | +23.98% | 32TCr | ||
| -1.99% | -3.22% | +21.20% | -9.14% | 6.86TCr | ||
| +0.25% | +2.36% | +34.94% | +93.69% | 919.73Cr | ||
| +0.34% | -0.73% | +6.41% | +0.09% | 852.47Cr | ||
| -3.05% | +0.42% | +6.92% | +28.13% | 404.28Cr | ||
| +1.53% | -1.00% | -18.56% | +3.79% | 419.78Cr | ||
| +1.87% | +5.04% | -37.18% | +24.94% | 356.42Cr | ||
| -0.81% | +7.81% | +12.16% | -16.29% | 225.77Cr | ||
| -3.46% | +13.29% | -11.84% | +40.22% | 200.61Cr | ||
| Average | -0.09% | +0.37% | +12.00% | +25.53% | 4.2TCr | |
| Weighted average by Cap. | +1.88% | -1.70% | +49.64% | +19.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 87Cr 76Cr 70Cr 64Cr 121.74Cr 8.36TCr 123.86Cr 836Cr 328.41Cr 4.08TCr 325.66Cr 318.51Cr 14TCr | 102.29Cr 89Cr 83Cr 76Cr 143.6Cr 9.86TCr 146.1Cr 986.11Cr 387.38Cr 4.81TCr 384.14Cr 375.7Cr 17TCr |
| Net income | 2.59Cr 2.27Cr 2.1Cr 1.92Cr 3.64Cr 249.8Cr 3.7Cr 25Cr 9.82Cr 121.99Cr 9.74Cr 9.52Cr 421.15Cr | 9.3Cr 8.13Cr 7.52Cr 6.9Cr 13Cr 896.09Cr 13Cr 90Cr 35Cr 437.59Cr 35Cr 34Cr 1.51TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $48.89 | +1.41% | 62,751 |
| 16/26/16 | $48.21 | +1.01% | 5,93,351 |
| 15/26/15 | $47.73 | +2.29% | 5,00,546 |
| 14/26/14 | $46.66 | -1.46% | 8,24,025 |
| 13/26/13 | $47.35 | -2.29% | 6,85,279 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















